Proceedings: The chronic leukemias: current therapeutic concepts.
D001966:Bromine / Q000627:therapeutic use; D002066:Busulfan / Q000627:therapeutic use; D002455:Cell Division; D002699:Chlorambucil / Q000627:therapeutic use; D002869:Chromosome Aberrations; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000235:genetics / Q000532:radiotherapy / Q000628:therapy*; D008213:Lymphocyte Activation; D008353:Mannitol / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013154:Spleen / Q000528:radiation effects; D013156:Splenectomy; D014750:Vincristine / Q000627:therapeutic use
D002699:Chlorambucil; D008353:Mannitol; D014750:Vincristine; D003520:Cyclophosphamide; D002066:Busulfan; D001966:Bromine; D011241:Prednisone; D006918:Hydroxyurea